ACHN
Achillion Pharmaceuticals
ACHN
ACHN
Delisted
ACHN was delisted on the 27th of January, 2020.
127 hedge funds and large institutions have $415M invested in Achillion Pharmaceuticals in 2018 Q1 according to their latest regulatory filings, with 17 funds opening new positions, 41 increasing their positions, 38 reducing their positions, and 36 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more funds holding in top 10
Funds holding in top 10: →
more capital invested
Capital invested by funds: $ → $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
15% less funds holding
Funds holding: 149 → 127 (-22)
53% less first-time investments, than exits
New positions opened: 17 | Existing positions closed: 36
Holders
127
Holding in Top 10
3
Calls
$3.12M
Puts
$259K
Top Buyers
| 1 | +$17.3M | |
| 2 | +$15.9M | |
| 3 | +$13.7M | |
| 4 |
Goldman Sachs
New York
|
+$9.98M |
| 5 |
Citadel Advisors
Miami,
Florida
|
+$7.94M |
Top Sellers
| 1 | -$23.5M | |
| 2 | -$16.7M | |
| 3 | -$7.42M | |
| 4 |
Renaissance Technologies
New York
|
-$4.85M |
| 5 |
BI
BVF Inc
San Francisco,
California
|
-$4.63M |